MTOR and cancer: In pancreatic cancer, m6A stimulates the PI3K/Akt/mTOR pathway, driving cancer cell proliferation (105, 106), whereas m1A and m5C are linked with activation of the mTOR pathway and unfavorable prognoses (107, 108).